Overview

Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Evaluation of the pharmacokinetic equivalence of two Docetaxel formulations in terms of AUC and Cmax
Phase:
Phase 1
Details
Lead Sponsor:
Samyang Biopharmaceuticals Corporation
Treatments:
Docetaxel